It is established that during chronic HBV infection there is a phase of high-level viral replication when the patient is HBe antigen (HBeAg) and HBV-DNA polvmerase (DNAp) positive. and this is followed bv a phase of chronic HBs Two patients with chronic persistent hepatitis and two with chronic active hepatitis, who were HBeAg positive and DNAp negative when first seen were studied prospectively (Fig. 2) . In two patients, HBeAg disappeared from the serum during follow' up. DNAp remained negative and anti-HBe appeared. In one patient HBeAg disappeared and anti-HBe appeared after two months; this, however, was followed by reappearance of HBeAg, which was still present, albeit together with anti-e, two months later. The fourth patient, whose DNAp had always been at the upper limit of the normal range, did not show evidence of seroconversion from HBeAg to anti-HBe throughout a two-year period. The only patient with a low liBeAg titre before treatment (case 6) had had a fourfold decline in DNAp during the previous two months: he was the only subject who had recently received steroids. There was no correlation between 1IBeAg and DNAp at this stage (r = (0069).
In the 'non-responders' there was a peak inhibition of DNAp seven days after starting treatment (Fig. 4) contrast. in the 'responders'. HBeAg titre began to decline at 28 days. reached a 50% reduction at 95±9 days, and disappeared after 235±24 days. The mean delav between DNAp and HBeAg disppearance from the serum in this group was 178±+2() davs. Anti-HBe appeared after 262±23 days in all the responders' and was alwavs absent in the 'nonresponders'. Serum HBV-DNA concentration in case 3 parallelled the changes in DNAp (Fig. 5) .
None of the treated patients studied lost HBsAg. While the concentration of HBsAg in the 'non- 
